HRL
45
-2
DE
62
-3
T
53
8
USB
61
-4
AFL
42
-7
GLW
46
-2
PAYX
51
-3
IR
65
-6
UAL
77
-3
ROK
51
-11
IP
67
2
GS
68
-5
HBAN
54
-2
NAVI
50
-5
UNP
42
-7
DUK
54
-3
VMC
57
-3
UPS
51
-7
MS
62
-7
JWN
59
2
HRL
45
-2
DE
62
-3
T
53
8
USB
61
-4
AFL
42
-7
GLW
46
-2
PAYX
51
-3
IR
65
-6
UAL
77
-3
ROK
51
-11
IP
67
2
GS
68
-5
HBAN
54
-2
NAVI
50
-5
UNP
42
-7
DUK
54
-3
VMC
57
-3
UPS
51
-7
MS
62
-7
JWN
59
2
Financhill
Back

Janux Therapeutics Stock Predictions

Time-Waster to Money-Maker: Join Mode Mobile's $1T Revolution

This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
34

JANX
Janux Therapeutics

Last Price:
69.99
Seasonality Move:
133.13%

7 Day Trial

ALL ACCESS PASS

$ 7

32,481% Growth: Invest in the Smartphone Revolution @ $0.26/Share

This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.

Janux Therapeutics Stock Forecast

  • Over the next 52 weeks, Janux Therapeutics has on average historically risen by 98.6% based on the past 3 years of stock performance.
  • Janux Therapeutics has risen higher in 1 of those 3 years over the subsequent 52-week period, corresponding to a historical accuracy of 33.33%
  • Is Janux Therapeutics Stock Undervalued?
    The current Janux Therapeutics [JANX] share price is $59.86. The Score for JANX is 34, which is 32% below its historic median score of 50, and infers higher risk than normal.
  • JANX is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.

Will Janux Therapeutics Stock Go Up Next Year?

  • Over the next 52 weeks, Janux Therapeutics has on average historically risen by 98.6% based on the past 3 years of stock performance.

Janux Therapeutics Stock Rating

Sell
34
Janux Therapeutics (JANX) is a Sell

Is Janux Therapeutics overpriced?

  • Janux Therapeutics has risen higher in 1 of those 3 years over the subsequent 52-week period, corresponding to a historical accuracy of 33.33%

Janux Therapeutics Stock Price History

Is JANX stock going to rise?

  • Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and JANX is experiencing selling pressure, which indicates risk of future bearish movement.

Stock Information

Stock Info

Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
januxrx.com

52-Week Data

52-Week High:
71.25
52-Week Low:
7.79

Prediction Charts

Market Cap:
3.14B
Price in USD:
59.86
Volume:
7.67M
Beta:
3.37

Technical Analysis

SMA50:
49.88
SMA100:
46.69
SMA200:
44.87
52-Wk Change:
562.17%

Stock Predictions

  • Is Janux Therapeutics stock public?
    Yes, Janux Therapeutics is a publicly traded company.
  • What is the Janux Therapeutics stock quote today?
    The Janux Therapeutics stock price is 59.86 USD today.
  • How to buy Janux Therapeutics stock online?
    You can buy Janux Therapeutics shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date Opening Closing Minimum Maximum
Nov-13 52.92 52.03 53.71 51.93
Nov-14 51.39 51.10 52.87 50.55
Nov-15 50.41 48.76 51.09 48.34
Nov-18 48.70 48.12 49.14 47.04
Nov-19 47.75 49.01 49.74 47.50
Nov-20 48.34 48.96 49.34 47.61
Nov-21 49.04 46.50 49.78 45.95
Nov-22 46.50 50.31 50.63 46.02
Nov-25 51.08 48.82 52.39 48.40
Nov-26 48.82 48.00 49.74 47.70
Nov-27 48.10 46.39 49.69 46.30
Nov-29 46.13 45.21 46.93 45.18
Dec-2 45.02 40.18 45.90 40.02
Dec-3 67.17 59.86 71.25 59.30

Janux Therapeutics Earnings

Janux Therapeutics Earnings Report: Per Share Janux Therapeutics Earnings Q1 Q2 Q3 and Q4 last year and next year.

Janux Therapeutics Forecast Revenue Growth

Janux Therapeutics Stock Analysis: Historical quarterly revenues per share for Janux Therapeutics and historical quarterly revenue growth:

  • Analysts estimate an earnings increase this quarter of $0.27 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.09 per share, and a decrease next year of $0.91 per share.

* Janux Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.